$YTENQ
YIELD10 BIOSCIENCE, INC. Stock $ytenq

$ytenq Overview Financials Valuation SEC Filings Company Website

2010 Q4 Form 10-K Financial Statement

#000104746912002477 Filed on March 12, 2012

Income Statement

Concept	2010 Q4	2009	2008 Q4
Revenue	$110.0K	$1.425M	$400.0K
YoY Change	-47.62%	-8.65%	-55.06%
Cost Of Revenue		$24.47M
YoY Change		-0.81%
Gross Profit		-$23.05M
YoY Change		-0.26%
Gross Profit Margin		-1617.54%
Selling, General & Admin	$3.840M	$15.68M	$3.590M
YoY Change	-5.42%	-0.61%	-13.08%
% of Gross Profit
Research & Development	$5.760M		$6.150M
YoY Change	-3.52%		14.53%
% of Gross Profit
Depreciation & Amortization	$450.0K	$2.734M	$970.0K
YoY Change	-36.62%	-26.7%	53.97%
% of Gross Profit
Operating Expenses	$9.600M	$15.68M	$9.740M
YoY Change	-4.29%	-0.61%	2.42%
Operating Profit		-$38.73M
YoY Change		-0.41%
Interest Expense	$20.00K	$772.0K	$440.0K
YoY Change	-71.43%	-73.29%	-68.57%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$9.470M	-$37.96M	-$8.900M
YoY Change	-2.97%	5.42%	23.27%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$9.470M	-$37.96M	-$8.900M
YoY Change	-2.97%	5.42%	23.27%
Net Earnings / Revenue	-8609.09%	-2663.86%	-2225.0%
Basic Earnings Per Share
Diluted Earnings Per Share	-$947.0M	-$3.796B	-$890.0M
COMMON SHARES
Basic Shares Outstanding		23.44M shares
Diluted Shares Outstanding		23.44M shares

Balance Sheet

Concept	2010 Q4	2009	2008 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$61.60M	$92.20M	$91.10M
YoY Change	-33.19%	1.21%	-16.65%
Cash & Equivalents	$12.53M	$10.80M	$26.19M
Short-Term Investments	$49.00M	$81.40M	$64.90M
Other Short-Term Assets	$800.0K	$800.0K	$500.0K
YoY Change	0.0%	60.0%	-28.57%
Inventory
Prepaid Expenses
Receivables	$800.0K	$400.0K	$200.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$63.26M	$93.40M	$91.80M
YoY Change	-32.27%	1.74%	-17.67%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.776M	$3.500M	$4.400M
YoY Change	-20.69%	-20.45%	-36.23%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$0.00
YoY Change
Other Assets	$117.0K	$700.0K	$700.0K
YoY Change	-83.29%	0.0%	16.67%
Total Long-Term Assets	$3.515M	$4.200M	$5.100M
YoY Change	-16.31%	-17.65%	-32.0%
TOTAL ASSETS
Total Short-Term Assets	$63.26M	$93.40M	$91.80M
Total Long-Term Assets	$3.515M	$4.200M	$5.100M
Total Assets	$66.77M	$97.60M	$96.90M
YoY Change	-31.59%	0.72%	-18.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$239.0K	$600.0K	$900.0K
YoY Change	-60.17%	-33.33%	200.0%
Accrued Expenses	$4.085M	$3.700M	$3.600M
YoY Change	10.41%	2.78%	-14.29%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.395M	$4.600M	$4.600M
YoY Change	39.02%	0.0%	-2.13%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$107.0K	$37.90M	$33.20M
YoY Change	-99.72%	14.16%	32.27%
Total Long-Term Liabilities	$107.0K	$37.90M	$33.20M
YoY Change	-99.72%	14.16%	32.27%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.395M	$4.600M	$4.600M
Total Long-Term Liabilities	$107.0K	$37.90M	$33.20M
Total Liabilities	$43.10M	$42.50M	$37.90M
YoY Change	1.4%	12.14%	27.18%
SHAREHOLDERS EQUITY
Retained Earnings	-$206.9M
YoY Change
Common Stock	$230.6M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$23.68M	$55.00M	$59.10M
YoY Change
Total Liabilities & Shareholders Equity	$66.77M	$97.60M	$96.90M
YoY Change	-31.59%	0.72%	-18.57%

Cashflow Statement

Concept	2010 Q4	2009	2008 Q4
OPERATING ACTIVITIES
Net Income	-$9.470M	-$37.96M	-$8.900M
YoY Change	-2.97%	5.42%	23.27%
Depreciation, Depletion And Amortization	$450.0K	$2.734M	$970.0K
YoY Change	-36.62%	-26.7%	53.97%
Cash From Operating Activities	-$8.080M	-$25.76M	-$3.690M
YoY Change	37.88%	40.08%	0.54%
INVESTING ACTIVITIES
Capital Expenditures	-$260.0K	$2.017M	-$40.00K
YoY Change	-76.58%	-355.32%	-94.94%
Acquisitions
YoY Change
Other Investing Activities	$6.400M	-$16.84M	$2.620M
YoY Change	-130.25%	-176.97%	-56.11%
Cash From Investing Activities	$6.150M	-$18.86M	$2.580M
YoY Change	-127.63%	-189.43%	-50.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$29.12M
YoY Change		3494.81%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	20.00K	29.23M	20.00K
YoY Change	-99.93%	3508.64%	-95.83%
NET CHANGE
Cash From Operating Activities	-8.080M	-25.76M	-3.690M
Cash From Investing Activities	6.150M	-18.86M	2.580M
Cash From Financing Activities	20.00K	29.23M	20.00K
Net Change In Cash	-1.910M	-15.39M	-1.090M
YoY Change	-285.44%	-538.46%	-155.33%
FREE CASH FLOW
Cash From Operating Activities	-$8.080M	-$25.76M	-$3.690M
Capital Expenditures	-$260.0K	$2.017M	-$40.00K
Free Cash Flow	-$7.820M	-$27.78M	-$3.650M
YoY Change	64.63%	57.82%	26.74%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2011	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-38785000	USD
CY2011	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	76000	USD
CY2009	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	120000	USD
CY2009	us-gaap	Revenue From Grants RevenueFromGrants	1143000	USD
CY2010	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26773755	shares
CY2009	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23435264	shares
CY2011	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31257376	shares
CY2011	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.24
CY2009	mblx	Cost Of Revenue Research And Development Expenses CostOfRevenueResearchAndDevelopmentExpenses	24471000	USD
CY2009	us-gaap	Sales Revenue Net SalesRevenueNet	1425000	USD
CY2009	mblx	Research And Development Revenue ResearchAndDevelopmentRevenue	152000	USD
CY2009	us-gaap	Licenses Revenue LicensesRevenue	10000	USD
CY2008Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26194000	USD
CY2009	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-15380000	USD
CY2009	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	29234000	USD
CY2010	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	104000	USD
CY2010	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	15000	USD
CY2010	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	5000	USD
CY2010	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-19000	USD
CY2010	us-gaap	Share Based Compensation ShareBasedCompensation	4696000	USD
CY2010	mblx	Charge For Company Common Stock Match ChargeForCompanyCommonStockMatch	443000	USD
CY2010	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1647000	USD
CY2010	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-38803000	USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	49407000	USD
CY2009	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	29118000	USD
CY2009	mblx	Proceeds From Options And Warrants Exercised ProceedsFromOptionsAndWarrantsExercised	116000	USD
CY2009	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-18855000	USD
CY2009	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	103048000	USD
CY2009	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	119956000	USD
CY2009	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	70000	USD
CY2009	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2017000	USD
CY2011	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	49333000	USD
CY2009	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-25759000	USD
CY2009	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	4519000	USD
CY2009	mblx	Increase Decrease In Deferred Rent And Other Long Term Liabilities IncreaseDecreaseInDeferredRentAndOtherLongTermLiabilities	-156000	USD
CY2009	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	334000	USD
CY2009	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-232000	USD
CY2009	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	205000	USD
CY2009	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	-53000	USD
CY2009	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-140000	USD
CY2009	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	70000	USD
CY2009	us-gaap	Share Based Compensation ShareBasedCompensation	4653000	USD
CY2011	mblx	Proceeds From Options And Warrants Exercised ProceedsFromOptionsAndWarrantsExercised	74000	USD
CY2009	mblx	Charge For Company Common Stock Match ChargeForCompanyCommonStockMatch	428000	USD
CY2009	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2734000	USD
CY2009	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-37957000	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-8908000	USD
CY2011	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	99464000	USD
CY2009Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10814000	USD
CY2011	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31257376	shares
CY2010	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-387000	USD
CY2011Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3574000	USD
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	-38861000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21277000	USD
CY2011	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	107477000	USD
CY2011	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	895000	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-31731000	USD
CY2011	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1333000	USD
CY2011	mblx	Increase Decrease In Deferred Rent And Other Long Term Liabilities IncreaseDecreaseInDeferredRentAndOtherLongTermLiabilities	-153000	USD
CY2011	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-623000	USD
CY2011	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	273000	USD
CY2011	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-68000	USD
CY2011	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	71000	USD
CY2011	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	296000	USD
CY2011	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	146000	USD
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	4633000	USD
CY2011	mblx	Charge For Company Common Stock Match ChargeForCompanyCommonStockMatch	529000	USD
CY2011	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1507000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12526000	USD
CY2010	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	1712000	USD
CY2010	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-9000	USD
CY2010	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	2339000	USD
CY2011	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	8751000	USD
CY2010	mblx	Proceeds From Options And Warrants Exercised ProceedsFromOptionsAndWarrantsExercised	2339000	USD
CY2010	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	31377000	USD
CY2010	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	116126000	USD
CY2010	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	83814000	USD
CY2010	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	29000	USD
CY2010	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	906000	USD
CY2010	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-31995000	USD
CY2010	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	341000	USD
CY2010	mblx	Increase Decrease In Deferred Rent And Other Long Term Liabilities IncreaseDecreaseInDeferredRentAndOtherLongTermLiabilities	-156000	USD
CY2010	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	329000	USD
CY2011	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-17000	USD
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	341000	USD
CY2011Q4	us-gaap	Liabilities Liabilities	43449000	USD
CY2011Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	35944000	USD
CY2011Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	221000	USD
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7165000	USD
CY2011Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2914000	USD
CY2011Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	165000	USD
CY2011Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	512000	USD
CY2011Q4	us-gaap	Assets Assets	82912000	USD
CY2011Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	72000	USD
CY2011Q4	us-gaap	Long Term Investments LongTermInvestments	1503000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2276000	USD
CY2011Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	622000	USD
CY2011Q4	us-gaap	Assets Current AssetsCurrent	78439000	USD
CY2011Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	823000	USD
CY2011Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	304000	USD
CY2011Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	311000	USD
CY2011Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	146000	USD
CY2011Q4	us-gaap	Short Term Investments ShortTermInvestments	55578000	USD
CY2010Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	66771000	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	23676000	USD
CY2010Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-206877000	USD
CY2010Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	165000	USD
CY2010Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4085000	USD
CY2010Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	239000	USD
CY2010Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-15000	USD
CY2010Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	230299000	USD
CY2010Q4	us-gaap	Common Stock Value CommonStockValue	269000	USD
CY2010Q4	us-gaap	Liabilities Liabilities	43095000	USD
CY2010Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	107000	USD
CY2010Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	36207000	USD
CY2010Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	386000	USD
CY2010Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6395000	USD
CY2010Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1906000	USD
CY2011Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2011Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2010Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26895389	shares
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34115798	shares
CY2010Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26895389	shares
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	34115798	shares
CY2010Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2010Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2010Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2010Q4	us-gaap	Assets Assets	66771000	USD
CY2010Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	117000	USD
CY2010Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2776000	USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	82912000	USD
CY2010Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	622000	USD
CY2010Q4	us-gaap	Assets Current AssetsCurrent	63256000	USD
CY2010Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	846000	USD
CY2010Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	8000	USD
CY2010Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	828000	USD
CY2010Q4	us-gaap	Short Term Investments ShortTermInvestments	49048000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	39463000	USD
CY2011Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-245662000	USD
CY2011Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-12000	USD
CY2011Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	284796000	USD
CY2011Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2010Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2011Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2010Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2010Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2011	us-gaap	Costs And Expenses CostsAndExpenses	40286000	USD
CY2011	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15841000	USD
CY2011	mblx	Cost Of Revenue Research And Development Expenses CostOfRevenueResearchAndDevelopmentExpenses	24445000	USD
CY2011	us-gaap	Sales Revenue Net SalesRevenueNet	1425000	USD
CY2011	us-gaap	Licenses Revenue LicensesRevenue	60000	USD
CY2011	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	447000	USD
CY2011	us-gaap	Revenue From Grants RevenueFromGrants	918000	USD
CY2010	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26773755	shares
CY2010	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.45
CY2010	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	136000	USD
CY2010	us-gaap	Operating Income Loss OperatingIncomeLoss	-38939000	USD
CY2010	us-gaap	Costs And Expenses CostsAndExpenses	39387000	USD
CY2010	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15714000	USD
CY2010	mblx	Cost Of Revenue Research And Development Expenses CostOfRevenueResearchAndDevelopmentExpenses	23673000	USD
CY2010	us-gaap	Sales Revenue Net SalesRevenueNet	448000	USD
CY2010	mblx	Research And Development Revenue ResearchAndDevelopmentRevenue	212000	USD
CY2010	us-gaap	Licenses Revenue LicensesRevenue	50000	USD
CY2010	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	122000	USD
CY2010	us-gaap	Revenue From Grants RevenueFromGrants	64000	USD
CY2009	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23435264	shares
CY2009	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.62
CY2009	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	772000	USD
CY2009	us-gaap	Operating Income Loss OperatingIncomeLoss	-38729000	USD
CY2009	us-gaap	Costs And Expenses CostsAndExpenses	40154000	USD
CY2009	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15683000	USD
CY2012Q1	dei	Entity Public Float EntityPublicFloat	58575840	USD

Files In Submission

Name	View Source	Status
0001047469-12-002477-index-headers.html	Edgar Link	pending
0001047469-12-002477-index.html	Edgar Link	pending
0001047469-12-002477.txt	Edgar Link	pending
0001047469-12-002477-xbrl.zip	Edgar Link	pending
a2208038z10-k.htm	Edgar Link	pending
a2208038zex-10_14.htm	Edgar Link	pending
a2208038zex-14_1.htm	Edgar Link	pending
a2208038zex-23_1.htm	Edgar Link	pending
a2208038zex-31_1.htm	Edgar Link	pending
a2208038zex-31_2.htm	Edgar Link	pending
a2208038zex-32_1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
g12213kmi001.jpg	Edgar Link	pending
g12213kmi002.jpg	Edgar Link	pending
g157308.jpg	Edgar Link	pending
mblx-20111231.xml	Edgar Link	completed
mblx-20111231.xsd	Edgar Link	pending
mblx-20111231_cal.xml	Edgar Link	unprocessable
mblx-20111231_def.xml	Edgar Link	unprocessable
mblx-20111231_lab.xml	Edgar Link	unprocessable
mblx-20111231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$YTENQ
YIELD10 BIOSCIENCE, INC. Stock $ytenq

2010 Q4 Form 10-K Financial Statement

#000104746912002477 Filed on March 12, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$YTENQ YIELD10 BIOSCIENCE, INC. Stock $ytenq

2010 Q4 Form 10-K Financial Statement

#000104746912002477 Filed on March 12, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$YTENQ
YIELD10 BIOSCIENCE, INC. Stock $ytenq